FDA Inspection 1121102 — Sharp Healthcare
The FDA completed an inspection of Sharp Healthcare on January 16, 2020 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 16, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- San Diego, CA (United States)
Additional Details
IRB